US President’s COVID Treatment Protocol Shows the ‘Effective Line of Treatment’

After a successful covid19 treatment at the hospital, the US President has now returned home but the urgency in knowing how his covid19 illness was treated is gaining momentum. So, here’s a detailed insight into as given by an article published in Science.

The Line of Treatment
  • On 2 October, the White House announced President Donald Trump received an experimental antibody treatment after a test revealed he’s infected with SARS-CoV-2.
  • At the time, he reportedly had mild COVID-19 symptoms,...

https://mfame.guru/us-presidents-covid-treatment-protocol-shows-the-effective-line-of-treatment/

Regeneron & Lilly Rooting Each Other in COVID19 Antibody Cocktail Success

Illustration of antibodies (red and blue) responding to an infection with the new coronavirus SARS-CoV-2 (purple). The virus emerged in Wuhan, China, in December 2019, and causes a mild respiratory illness (covid-19) that can develop into pneumonia and be fatal in some cases. The coronaviruses take their name from their crown (corona) of surface proteins, which are used to attach and penetrate their host cells. Once inside the cells, the particles use the cells’ machinery to make more copies of...

https://mfame.guru/regeneron-lilly-rooting-each-other-in-covid19-antibody-cocktail-success/

Regeneron’s COVID19 Antibody Cocktail Trial Shows Promising Results

President Trump Treated With Experimental COVID Drug Developed Out of Westchester – NBC New York
Doctor’s hand with medical glove and a test tube

In a major development, the Biotechnology company Regeneron released some early results of tests using its antibody cocktail in coronavirus patients Tuesday and said it seemed to reduce levels of the virus and improve symptoms in patients, reports CNN.

It’s the same therapy that’s being used to treat the US President at the moment

The greatest improvements were seen in patients who hadn’t already mounted a natural response to the infection, the...

https://mfame.guru/regenerons-covid19-antibody-cocktail-trial-shows-promising-results/